#742 — The Industry Wire

  1. Trump administration plans 100% tariff on imported drugs.
  2. FDA to launch safety review of abortion pill.
  3. ACA subsidy expiration could cost hospitals $32B.
  4. Medicare Advantage firms laud RADV court ruling.
  5. PBMs hope to head off reform efforts.
  6. GAO report probes costs of Georgia’s Medicare work rule.
  7. CommonSpirit cuts fiscal 2025 operating loss to $225M.
  8. FDA approves eyeglass lenses for nearsighted kids.
  9. Huntington’s disease treated for first time
  10. New obesity drug could work better than GLP-1s.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like